HOWL - Werewolf Therapeutics GAAP EPS of -$0.33 revenue of $1.5M March, 07 2024 11:27 AM Werewolf Therapeutics Inc. 2024-03-07 11:27:31 ET More on Werewolf Therapeutics Werewolf Therapeutics: Still In The Race To Develop Next Generation Cytokines Seeking Alpha’s Quant Rating on Werewolf Therapeutics Historical earnings data for Werewolf Therapeutics Financial information for Werewolf Therapeutics For further details see: Werewolf Therapeutics GAAP EPS of -$0.33, revenue of $1.5M